Free Trial

B. Riley Has Pessimistic Outlook of IperionX FY2025 Earnings

IperionX logo with Industrials background

Key Points

  • B. Riley has revised its earnings estimate for IperionX, projecting a loss of ($0.12) per share for FY2025, down from a previous estimate of ($0.08).
  • The consensus estimate for IperionX's full-year earnings currently stands at ($0.08) per share, indicating concerns about profitability.
  • Despite the pessimistic forecast, the stock has received a "buy" rating from Roth Capital, with a target price of $64.00, and the average rating for the stock is currently "Buy" with a target of $46.00.
  • Interested in IperionX? Here are five stocks we like better.

IperionX Limited Sponsored ADR (NASDAQ:IPX - Free Report) - B. Riley cut their FY2025 earnings estimates for IperionX in a research report issued on Thursday, September 11th. B. Riley analyst N. Giles now forecasts that the company will post earnings of ($0.12) per share for the year, down from their prior forecast of ($0.08). The consensus estimate for IperionX's current full-year earnings is ($0.08) per share. B. Riley also issued estimates for IperionX's FY2026 earnings at ($0.07) EPS, FY2027 earnings at $0.08 EPS and FY2028 earnings at $0.43 EPS.

IPX has been the topic of a number of other research reports. Roth Capital assumed coverage on shares of IperionX in a research report on Wednesday, August 20th. They issued a "buy" rating and a $64.00 price target on the stock. Wall Street Zen raised shares of IperionX from a "sell" rating to a "hold" rating in a research report on Friday, June 6th. Two analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, IperionX currently has a consensus rating of "Buy" and a consensus price target of $46.00.

View Our Latest Report on IperionX

IperionX Trading Down 4.5%

Shares of NASDAQ:IPX traded down $1.97 during trading on Monday, reaching $42.09. The stock had a trading volume of 602,411 shares, compared to its average volume of 92,694. IperionX has a 52 week low of $12.27 and a 52 week high of $49.46. The stock has a fifty day simple moving average of $41.08 and a two-hundred day simple moving average of $28.95.

Institutional Investors Weigh In On IperionX

Institutional investors and hedge funds have recently made changes to their positions in the company. Thomist Capital Management LP acquired a new position in IperionX during the 2nd quarter valued at about $59,384,000. Osaic Holdings Inc. boosted its position in shares of IperionX by 7.7% during the second quarter. Osaic Holdings Inc. now owns 70,325 shares of the company's stock worth $2,215,000 after purchasing an additional 5,000 shares in the last quarter. Jane Street Group LLC boosted its position in shares of IperionX by 73.8% during the second quarter. Jane Street Group LLC now owns 55,558 shares of the company's stock worth $1,750,000 after purchasing an additional 23,591 shares in the last quarter. Bank of America Corp DE increased its stake in IperionX by 69.0% during the 2nd quarter. Bank of America Corp DE now owns 35,441 shares of the company's stock worth $1,116,000 after purchasing an additional 14,467 shares in the last quarter. Finally, OLD Mission Capital LLC bought a new stake in IperionX during the 1st quarter worth approximately $477,000. Institutional investors and hedge funds own 2.76% of the company's stock.

IperionX Company Profile

(Get Free Report)

IperionX's mission is to be the leading developer of low carbon, sustainable, critical material supply chains focused on advanced industries including space, aerospace, electric vehicles and 3D printing. IperionX's breakthrough titanium technologies have demonstrated the potential to produce titanium products that are sustainable, 100% recyclable, have low carbon intensity and to do so at product qualities that meet or exceed current industry standards.

Featured Articles

Should You Invest $1,000 in IperionX Right Now?

Before you consider IperionX, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and IperionX wasn't on the list.

While IperionX currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.